98 Chapter 4 14. Habets EJJ, Dirven L, Wiggenraad RG, et al. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: A prospective study. Neuro Oncol. 2016;18(3):435-444. doi:10.1093/neuonc/nov186 15. Hodgson KD, Hutchinson AD, Wilson CJ, Nettelbeck T. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39(3):297-304. doi:10.1016/j.ctrv.2012.11.001 16. Joly F, Castel H, Tron L, Lange M, Vardy J. Potential effect of immunotherapy agents on cognitive function in cancer patients. J Natl Cancer Inst. 2020;112(2):123127. doi:10.1093/JNCI/DJZ168 17. Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267-275. doi:10.1007/s11910-012-0264-9 18. Schagen SB, Tsvetkov AS, Compter A, Wefel JS. Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach? Nat Rev Neurol. 2022;18(3):173-185. doi:10.1038/s41582-021-00617-2 19. Schimmel WCM, Verhaak E, Bakker M, Hanssens PEJ, Sitskoorn MM, Gehring K. Group and Individual Change in Cognitive Functioning in Patients With 1 to 10 Brain Metastases Following Gamma Knife Radiosurgery. Clin Oncol. 2021;33(5):314-321. doi:10.1016/j.clon.2021.01.003 20. van der Meer PB, Habets EJJ, Wiggenraad RG, et al. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy. J Neurooncol. 2018;139(2):359-368. doi:10.1007/s11060-018-2868-7 21. Jacobson NS, Roberts LJ, Berns SB, McGlinchey JB. Methods for defining and determining the clinical significance of treatment effects: Description, application, and alternatives. J Consult Clin Psychol. 1999;67(3):300-307. doi:10.1037/0022-006X.67.3.300 22. Jacobson NS, Truax P. Clinical Significance: A Statistical Approach to Denning Meaningful Change in Psychotherapy Research. Journal of Consulting and Clinical Psychologv. 1991;59(1):12-19. 23. van Grinsven E, Cialdella F, Verhoeff J, Philippens M, Zandvoort M. Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy. Journal of Psycho-oncology. 2023;32(11):1752-1761. 24. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi:10.1093/acprof:oso/9780199241323.003.0025 25. Schoo LA, Van Zandvoort MJE, Biessels GJ, Kappelle LJ, Postma A. Insight in cognition: Self-awareness of performance across cognitive domains. Appl Neuropsychol. 2013;20(2):95-102. doi:10.1080/09084282.2012.670144 26. Wefel JS, Vardy J, Ahles T, Schagen SB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011;12(7):703-708. doi:10.1016/S1470-2045(10)702941 27. Duff K. Current topics in science and practice evidence-based indicators of neuropsychological change in the individual patient: Relevant concepts and methods. Archives of Clinical Neuropsychology. 2012;27(3):248-261. doi:10.1093/ arclin/acr120 28. Verhage F. Intelligentie en leeftijd bij volwassenen en bejaarden. Koninklijke van Gorcum. Published online 1964. https://research.rug.nl/en/publications/ intelligentie-en-leeftijd-bij-volwassenen-en-bejaarden
RkJQdWJsaXNoZXIy MTk4NDMw